/Extraordinary income/(expense) (7) (6) (8) (12%) 30 170 (83%) Acquisition cost and pre-operative expense, (7) (5) (8) (11%) (29) (32) (11%) Gain on Bargain Purchases, impairments and feasibility study(Net)1 1 (0
Operational/Extraordinary income/(expense) (0) 52 (6) - 99% Acquisition cost and pre-operative expense (8) (3) (5) (151)% (74)% Gain on Bargain Purchases and impairments (Net)1 (1) 62 (0) - (1566)% Other
, before extraordinary items (34) (13) 93 (163)% (136)% Add: Non Operational/Extraordinary income/(expense) 52 (34) 24 252% 114% Acquisition cost and pre-operative expense (3) (7) (7) 53% 56% Gain on Bargain
Checklist คุณสมบัติตามเกณฑ์ share swap
million (THB 8.4 billion), -7% YoY, Core EBITDA margin 10% Core Net profit after tax of $128 million (THB 4.0 billion), -27% YoY Core Earnings Per Share of THB 0.67, -32% YoY Operating Cash Flow of
of $304 million (THB 9.6 billion), -7% YoY, Core EBITDA margin 10% Core Net profit after tax of $128 million (THB 4.0 billion), -27% YoY Core Earnings Per Share of THB 0.67, -32% YoY Operating
2018 MD&A 5 o Avgol enhances IVL's HVA portfolio and market share in the hygiene segment and as the leading producer in Russia and India. o Kordarna (completed 30 Oct, 2018) - propels IVL to a leading
asset base in the Americas 21-Mar-18 (Signed: 21-May-18) 2020E (start-up) Avgol Enhances IVL’s HVA portfolio and market share in the personal hygiene segment Accelerates IVL’s global expansion and
)% Acquisition cost & pre-operative expense (3) (2) (1) (9) (3) 207% Gain on Bargain Purchases, impairments and feasibility study (Net)* (0) - 74 4 154 (97)% Other Extraordinary Income/(Expense) 0 1 (2) 18 (3
income/(expense) (40) (3) 12 (39) 163 Acquisition cost & pre-operative expense (4) (3) (0) (12) (3) 312% Gain on Bargain Purchases, impairments and feasibility study (Net)* (35) (0) 13 (44) 169 Other